This weekly recap focuses on keeping COVID-19 vaccines moving to save more lives; why we need a national commission to investigate the U.S. Capitol attack; media literacy as a tool to counter “Truth Decay,” and more.
The United States is waiting to be vaccinated against COVID-19 and millions of doses wait for arms. Policymakers at the national, state, and local levels have been stockpiling the shots for many reasons. While supply ramps up, policymakers could push to deliver vaccine to people instead of freezers.
Pennsylvania state and county health departments have a number of options that could speed the delivery of COVID-19 vaccines to make sure Pennsylvania residents at high risk for severe COVID-19 outcomes are vaccinated as soon as possible.
The disorganized public health response to the COVID-19 pandemic in the United States helped ensure that the nation led the world in infections nearly from the beginning of the pandemic. With vaccines now becoming available, are we over the problem? Not necessarily.
As the first COVID-19 vaccines are being administered across the United States, countless questions have arisen about what comes next. Is one vaccine better than another? Can the United States both speed up inoculation and overcome some people's hesitance to get the shot? RAND experts offer insights into the historic vaccine rollout.
The cover story on the ’Internet of Bodies’ highlights the perils of devices that track personal health data and provide medical treatment. Other columns explore vaccine hesitancy, the high price of insulin in the U.S., and social justice in America.
In the context of the pandemic, buprenorphine prescribers quickly transitioned to providing telemedicine visits in high volume; nonetheless, there are still many unknowns, including the quality and safety of widespread use of telemedicine for OUD treatment.
Vaccine nationalism, in which countries prioritize their domestic needs at the expense of others, will have significant global economic consequences. Major economies actually have more to gain by helping to make an effective COVID-19 vaccine widely available globally.
Laura Bogart, a senior behavioral scientist, studies how discrimination feeds medical mistrust and conspiracy beliefs. Her research on how mistrust became a barrier to treatment for Black Americans during the HIV epidemic sheds light on why some might question the safety of a COVID-19 vaccine.
Most agree that America's 18 million health care workers should top the list for COVID-19 vaccination. The 3.3 million teachers should come next. Vaccinating teachers could make it possible to open schools permanently and get parents back to work. That would help the economy recover.
Concern about potential COVID-19 vaccine side effects and their consequences may be contributing to Americans' reluctance to get vaccinated. Policymakers and the public should carefully consider what types and levels of compensation for any adverse effects of vaccination are truly fair and appropriate.
Researchers used a global macroeconomic model to examine the economic effects of vaccine nationalism. This brief highlights the cost to 30 high-income countries if low and middle-income countries miss out on initial access to COVID-19 vaccines.
With emergency use authorization for the first COVID-19 vaccine now in place, states and localities have turned their focus to the logistics of dispensing it as quickly as feasible. Still, uncertainties abound. It is essential to build a process of learning into the plan.